APA aipamena

Rathore, K., & Cekanova, M. (2015). A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro. Drug Des Devel Ther.

Chicago Style aipamena

Rathore, Kusum, and Maria Cekanova. "A Novel Derivative of Doxorubicin, AD198, Inhibits Canine Transitional Cell Carcinoma and Osteosarcoma Cells in Vitro." Drug Des Devel Ther 2015.

MLA aipamena

Rathore, Kusum, and Maria Cekanova. "A Novel Derivative of Doxorubicin, AD198, Inhibits Canine Transitional Cell Carcinoma and Osteosarcoma Cells in Vitro." Drug Des Devel Ther 2015.